Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T16:58:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    1%
    Check dated 2024-12-14T12:10:44.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Several links related to lymphoma and rare diseases have been removed, along with various clinical trial data fields and options for downloading study information.
    Difference
    2%
    Check dated 2024-11-23T03:51:46.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to lymphoma and clinical trials, while the previous version 2.12.1 has been removed.
    Difference
    2%
    Check dated 2024-11-15T22:13:20.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T10:58:15.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:48:32.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.